Evidence map›Paper›PMID 38045863›Full record

ArticleIJID regions2024

Evaluation of treatment outcomes among adult patients diagnosed with tuberculosis in Ghana: A 10 year retrospective review.

Peter Puplampu, Isaac Kyeremateng, Olive Asafu-Adjaye, Anita Ago Asare, Kofi Agyabeng, Roderick Sarkodee, Oladele Oluwakemi, Vincent Ganu

Abstract read
In one paragraph

Article in IJID regions, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Peter PuplampuDepartment of Medicine & Therapeutics, University of Ghana Medical School, Accra, Ghana.
Isaac KyerematengGhana Health Service, Accra, Ghana.
Olive Asafu-AdjayeGreater Accra Regional Hospital, Accra, Ghana.
Anita Ago AsareInfectious disease unit, Department of Medicine, Korle Bu Teaching Hospital, Accra, Ghana.
Kofi AgyabengDepartment of Biostatistics, School of Public Health, University of Ghana, Accra, Ghana.
Roderick SarkodeeInfectious disease unit, Department of Medicine, Korle Bu Teaching Hospital, Accra, Ghana.
Oladele OluwakemiInfectious disease unit, Department of Medicine, Korle Bu Teaching Hospital, Accra, Ghana.
Vincent GanuInfectious disease unit, Department of Medicine, Korle Bu Teaching Hospital, Accra, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The study determined tuberculosis (TB) treatment outcomes in Southern Ghana from 2012 to 2021. Methods: A retrospective analysis of service data on TB cases was conducted. Treatment success was defined as TB cure or completion of treatment course, whereas unsuccessful outcomes was defined as death, failure of treatment and lost to follow up. Bivariate and multivariate logistic regression was used to determine factors associated with treatment outcomes. Results: A total of 4106 adult TB cases were reported with a median age of 41 (interquartile range 32-52) years. Of these, 93.1% (n = 3823) were newly diagnosed. The treatment success rate declined from 71.0% in 2012 to 55.7% in 2021 (ktau-b = -0.56, Conclusion: Tuberculosis treatment success rate declined over the period. There is a need for the TB Control Programme to review the national and sub-national TB data to ascertain poor performing TB treatment sites to identify and address context specific challenges with treatment interventions and system inadequacies to improve treatment success rates.

Indexed as

Clinically diagnosedExtra-pulmonaryOutcomeTreatment success rateTuberculosis

Identifiers

PMID38045863
PMCPMC10687693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.